Concepedia

K. De Leeuw

KD

5

Publications

420

Citations

5

H-Index

1991

Active since

Affiliations

Erasmus University Rotterdam(Current)

Rotterdam University of Applied Sciences

K. De Leeuw is an author at Erasmus University Rotterdam specializing in cancer research, cancer therapeutics, and radiation oncology.

Top concepts

Publications per year

1991–2004

5

Publications

5

Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells

PA te Boekhorst, K. De Leeuw, M. Schoester et al. · Blood · 1993 · 157 citations · Full text

A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors

A. S. T. Planting, Pieter Sonneveld, Ate van der Gaast et al. · Cancer Chemotherapy and Pharmacology · 2004 · 106 citations

, , +6

Clinical modulation of multidrug resistance in multiple myeloma: effect of cyclosporine on resistant tumor cells.

Pieter Sonneveld, M. Schoester, K. De Leeuw · Journal of Clinical Oncology · 1994 · 81 citations

High expression of the multidrug resistance P-glycoprotein in high-risk myelodysplasia is associated with immature phenotype.

Pieter Sonneveld, Jacques J. M. van Dongen, A. Hagemeijer et al. · PubMed · 1993 · 53 citations

<i>In vitro</i> Ig‐synthesis and proliferative activity in multiple myeloma are stimulated by different growth factors

Pieter Sonneveld, Martijn Schoester, K. De Leeuw · British Journal of Haematology · 1991 · 23 citations

Rows per page

1–5 of 5